Bisandrographolide A is primarily studied for its potential anti-inflammatory and immunomodulatory applications. It has shown activity in reducing pro-inflammatory cytokines, making it a candidate for research in autoimmune and chronic inflammatory conditions. The compound also exhibits antiviral properties, particularly in inhibiting viral replication in certain respiratory viruses, suggesting possible use in antiviral therapies. Additionally, it is being explored for hepatoprotective effects, supporting liver health and function in toxin-induced damage models. Due to its bioactive profile, Bisandrographolide A is of interest in the development of natural product-based pharmaceuticals targeting immune regulation and infection control.